1 study found for:    21763935 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
TMC278-TiDP6-C215: A Clinical Trial in Treatment Naive HIV-subjects Patients Comparing TMC278 to Efavirenz in Combination With 2 Nucleoside/Nucleotide Reverse Transcriptase Inhibitors
Conditions: HIV Infections;   HIV-1
Interventions: Drug: TMC278;   Drug: efavirenz

Indicates status has not been verified in more than two years